Get started
Author

Jonas Eriksson

Observed name: Eriksson, Jonas
ORCID: 0000-0003-0241-092X
Observed ORCID: 0000-0003-0241-092X
OpenAlex ID: A5121385151
Pretargeted brain PET imaging reveals amyloid-β pathology using a TCO-modified antibody and a fluorine-18-labeled tetrazine
2025 · Sara Lopes van den Broek, Jonas Eriksson, et al. · Translational Neurodegeneration · 3
PDF
Regional [ 18 F]RO948 tau-PET across the AD continuum in relation to plasma biomarkers, cognition and atrophy
2025 · Mariola Zapater-Fajari, Marco Bucci, et al. · medRxiv · 1
[ 18 F]RO948 Tau PET Imaging in Early and Late‐Onset Alzheimer's Disease: Regional Evolution and Correlations with Plasma Biomarkers
2025 · Mariola Zapater‐Fajari, Marco Bucci, et al. · Alzheimer s & Dementia
PDF
[18F] RO948 Tau PET imaging and plasma biomarkers in PART and LATE patients compared with sporadic Alzheimer's Disease
2025 · Agneta K Nordberg, Marco Bucci, et al. · Alzheimer s & Dementia
PDF
Additional file 2 of Pretargeted brain PET imaging reveals amyloid-β pathology using a TCO-modified antibody and a fluorine-18-labeled tetrazine
2025 · Lopes van den Broek, Sara, Eriksson, Jonas, et al. · Figshare
Additional file 1 of Pretargeted brain PET imaging reveals amyloid-β pathology using a TCO-modified antibody and a fluorine-18-labeled tetrazine
2025 · Lopes van den Broek, Sara, Eriksson, Jonas, et al. · Figshare
Pretargeted brain PET imaging reveals amyloid-β pathology using a TCO-modified antibody and a fluorine-18-labeled tetrazine
2025 · Lopes van den Broek, Sara, Eriksson, Jonas, et al. · Figshare
Works count: 7
Citation count: 4
H-index: 1
I10-index:
Year
Topic
Type